|
V.TLT
|
Agreed. In the world of microcaps, expect the unexpected (both negative and...
|
|
V.TLT
|
I get it, excellent point. Thanks for the reply.
|
|
V.TLT
|
Any idea why he'd only mention the 90 day CR% ? Probably due to...
|
|
V.TLT
|
@Not, I hope they're beyond that stage also, but if they aren't.... I...
|
|
V.TLT
|
I haven't seen a reply yet that indicates anyone on this board was aware...
|
|
V.TLT
|
SF, thanks and understood. My point was only regarding the pre-BTD advice...
|
|
V.TLT
|
Not sure what you're trying to say, but if the FDA says you can revise...
|
|
V.TLT
|
Drug application. I posted initially b/c of Dr Uddin's comments in the...
|
|
V.TLT
|
I think I found the answer here, question #23: https://www.fda.gov/regulatory...
|
|
V.TLT
|
I've never heard of a pre-BTD submission to the FDA, but maybe some of...
|
|
V.TLT
|
@DJ. Aha, thanks! So they mean 51% of all enrolled patients end up being CR...
|
|
V.TLT
|
As far as I can tell, the question is related to the quote. 51% of enrolled...
|
|
V.TLT
|
DJ, the quote that NotPoop showed says "enrolled patients" not...
|
|
V.TLT
|
I know science doesn't always work this way, but if Ruvidar works this...
|
|
V.TLT
|
I had the same thought. As in, excellent update after such confusing...
|
|
V.TLT
|
You meant 15 months, not 18, right? Hard to keep up with all the ins and outs...
|
|
V.TLT
|
Right, the lack of clarity is on the company. It's very simple, if the...
|
|
V.TLT
|
Thanks CS. I'd have to be knowledgeable on the subject in order to...
|
|
V.TLT
|
CS, if BTD app doesn't require the 450 day data then what's your view...
|
|
V.TLT
|
Can/should they include the undertreated in any timeframes if they're...
|